Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2023

Feb 17, 2023

34576_dirs_2023-02-17_4b49270c-7a2d-4c36-b8c6-67532776a760.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5/A — Form 5/A

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2022-12-31

Reporting Person: Wettig Thane (Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-05-25 Common Stock G 1988 $0.00 Disposed 87175 Direct
2022-08-22 Common Stock G 1820 $0.00 Disposed 85355 Direct